3 completed, 2 unknown, 1 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 3, Unknown 2, Terminated 1 |
Follow Hypertrophic Cardiomyopathy: new trials by email Literature Review of Hypertrophic Cardiomyopathy trials Research Report on Hypertrophic Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of SGLT2i in noHCM With HFpEF Empagliflozin 10 MG - Hypertrophic Cardiomyopathy, Heart Failure With Preserved Ejection Fraction | Phase 4 | Unknown | China National Center for Cardiovascular Diseases | 94 | 2022-08-01 | 2024-05-06 |
| Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy Metoprolol - Hypertrophic Cardiomyopathy | Phase 4 | Completed | University Hospital, Motol | 22 | 2020-03-05 | 2023-05-10 |
| Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy Spironolactone - Hypertrophic Cardiomyopathy, Fibrosis | Phase 4 | Unknown | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 260 | 2018-05-14 | 2018-05-09 |
| Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve Regadenoson, Adenosine - Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy | Phase 4 | Terminated | Duke University | 31 | 2017-09-05 | 2020-09-16 |
| Ranolazine for the Treatment of Chest Pain in HCM Patients Ranolazine - Hypertrophic Cardiomyopathy | Phase 4 | Completed | Duke University | 14 | 2012-11-01 | 2017-03-03 |
| Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy Spironolactone, Placebo - Myocardial Fibrosis, Hypertrophic Cardiomyopathy | Phase 4 | Completed | Tufts Medical Center | 53 | 2007-11-01 | 2021-04-27 |
Cardiomyopathy, Hypertrophic (6) · Fibrosis (2) · Chest Pain (1) · Dyspnea (1) · Ventricular Outflow Obstruction, Left (1)
Aortic Stenosis, Subvalvular (6) · Aortic Valve Disease (6) · Aortic Valve Stenosis (6) · Cardiomyopathies (6) · Cardiovascular Diseases (6) · Heart Diseases (6) · Heart Valve Diseases (6) · Pathological Conditions, Signs and Symptoms (3) · Pathologic Processes (2) · Neurologic Manifestations (1) · Pain (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Spironolactone (2) · Adenosine (1) · Metoprolol (1) · Ranolazine (1) · empagliflozin (1) · regadenoson (1)
Duke University (2) · China National Center for Cardiovascular Diseases (1) · Tufts Medical Center (1) · University Hospital, Motol (1) · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)
United States (3) · China (2) · Czechia (1)
Han Kim (1) · Josef Veselka, MD, PhD (1) · Martin S Maron, MD (1) · Yi-Gang Li, MD (1)